TY - JOUR
T1 - Prediction models of incontinence and sexual function one year after radical prostatectomy based on data from 20 164 prostate cancer patients
AU - Sibert, Nora Tabea
AU - Kurth, Tobias
AU - Breidenbach, Clara
AU - Wesselmann, Simone
AU - Feick, Günther
AU - Carl, Ernst-Günter
AU - Dieng, Sebastian
AU - Albarghouth, Mohamad Hatem
AU - Aziz, Atiqullah
AU - Baltes, Stefan
AU - Bartolf, Elisabeth
AU - Bedke, Jens
AU - Blana, Andreas
AU - Brock, Marko
AU - Conrad, Stefan
AU - Darr, Christopher
AU - Distler, Florian
AU - Drosos, Konstantinos
AU - Duwe, Gregor
AU - Gaber, Amr
AU - Giessing, Markus
AU - Harke, Nina Natascha
AU - Heidenreich, Axel
AU - Hijazi, Sameh
AU - Hinkel, Andreas
AU - Kaftan, Björn Theodor
AU - Kheiderov, Shatlyk
AU - Knoll, Thomas
AU - Lümmen, Gerd
AU - Peters, Inga
AU - Polat, Bülent
AU - Schrodi, Valentin
AU - Stolzenburg, Jens-Uwe
AU - Varga, Zoltan
AU - von Süßkind-Schwendi, Julius
AU - Zugor, Vahudin
AU - Kowalski, Christoph
N1 - Distler: Klinikum Nürnberg, Nürnberg, Germany
PY - 2023
Y1 - 2023
N2 - BACKGROUND: Incontinence and sexual dysfunction are long-lasting side effects after surgical treatment (radical prostatectomy, RP) of prostate cancer (PC). For an informed treatment decision, physicians and patients should discuss expected impairments. Therefore, this paper firstly aims to develop and validate prognostic models that predict incontinence and sexual function of PC patients one year after RP and secondly to provide an online decision making tool.METHODS: Observational cohorts of PC patients treated between July 2016 and March 2021 in Germany were used. Models to predict functional outcomes one year after RP measured by the EPIC-26 questionnaire were developed using lasso regression, 80-20 splitting of the data set and 10-fold cross validation. To assess performance, R2, RMSE, analysis of residuals and calibration-in-the-large were applied. Final models were externally temporally validated. Additionally, percentages of functional impairment (pad use for incontinence and firmness of erection for sexual score) per score decile were calculated to be used together with the prediction models.RESULTS: For model development and internal as well as external validation, samples of 11 355 and 8 809 patients were analysed. Results from the internal validation (incontinence: R2 = 0.12, RMSE = 25.40, sexual function: R2 = 0.23, RMSE = 21.44) were comparable with those of the external validation. Residual analysis and calibration-in-the-large showed good results. The prediction tool is freely accessible: https://nora-tabea.shinyapps.io/EPIC-26-Prediction/.CONCLUSION: The final models showed appropriate predictive properties and can be used together with the calculated risks for specific functional impairments. Main strengths are the large study sample (> 20 000) and the inclusion of an external validation. The models incorporate meaningful and clinically available predictors ensuring an easy implementation. All predictions are displayed together with risks of frequent impairments such as pad use or erectile dysfunction such that the developed online tool provides a detailed and informative overview for clinicians as well as patients.
AB - BACKGROUND: Incontinence and sexual dysfunction are long-lasting side effects after surgical treatment (radical prostatectomy, RP) of prostate cancer (PC). For an informed treatment decision, physicians and patients should discuss expected impairments. Therefore, this paper firstly aims to develop and validate prognostic models that predict incontinence and sexual function of PC patients one year after RP and secondly to provide an online decision making tool.METHODS: Observational cohorts of PC patients treated between July 2016 and March 2021 in Germany were used. Models to predict functional outcomes one year after RP measured by the EPIC-26 questionnaire were developed using lasso regression, 80-20 splitting of the data set and 10-fold cross validation. To assess performance, R2, RMSE, analysis of residuals and calibration-in-the-large were applied. Final models were externally temporally validated. Additionally, percentages of functional impairment (pad use for incontinence and firmness of erection for sexual score) per score decile were calculated to be used together with the prediction models.RESULTS: For model development and internal as well as external validation, samples of 11 355 and 8 809 patients were analysed. Results from the internal validation (incontinence: R2 = 0.12, RMSE = 25.40, sexual function: R2 = 0.23, RMSE = 21.44) were comparable with those of the external validation. Residual analysis and calibration-in-the-large showed good results. The prediction tool is freely accessible: https://nora-tabea.shinyapps.io/EPIC-26-Prediction/.CONCLUSION: The final models showed appropriate predictive properties and can be used together with the calculated risks for specific functional impairments. Main strengths are the large study sample (> 20 000) and the inclusion of an external validation. The models incorporate meaningful and clinically available predictors ensuring an easy implementation. All predictions are displayed together with risks of frequent impairments such as pad use or erectile dysfunction such that the developed online tool provides a detailed and informative overview for clinicians as well as patients.
KW - Male
KW - Humans
KW - Erectile Dysfunction/etiology
KW - Penile Erection
KW - Urinary Incontinence/etiology
KW - Prostatic Neoplasms/surgery
KW - Prostatectomy/adverse effects
U2 - 10.1371/journal.pone.0295179
DO - 10.1371/journal.pone.0295179
M3 - Original Article
C2 - 38039308
SN - 1932-6203
VL - 18
SP - e0295179
JO - PLOS ONE
JF - PLOS ONE
IS - 12
ER -